CN1094345C - 高剂量脂质体气溶胶制剂 - Google Patents

高剂量脂质体气溶胶制剂 Download PDF

Info

Publication number
CN1094345C
CN1094345C CN97196141A CN97196141A CN1094345C CN 1094345 C CN1094345 C CN 1094345C CN 97196141 A CN97196141 A CN 97196141A CN 97196141 A CN97196141 A CN 97196141A CN 1094345 C CN1094345 C CN 1094345C
Authority
CN
China
Prior art keywords
liposome
budesonide
aerosol composition
dlpc
cyclosporin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN97196141A
Other languages
English (en)
Chinese (zh)
Other versions
CN1224347A (zh
Inventor
J·C·沃尔德莱普
V·奈特
M·B·布莱克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RESEARCH DEVELOPMENT FOUDATION
Original Assignee
RESEARCH DEVELOPMENT FOUDATION
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/731,605 external-priority patent/US5958378A/en
Application filed by RESEARCH DEVELOPMENT FOUDATION filed Critical RESEARCH DEVELOPMENT FOUDATION
Publication of CN1224347A publication Critical patent/CN1224347A/zh
Application granted granted Critical
Publication of CN1094345C publication Critical patent/CN1094345C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN97196141A 1996-07-03 1997-07-02 高剂量脂质体气溶胶制剂 Expired - Fee Related CN1094345C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US67565496A 1996-07-03 1996-07-03
US08/675,654 1996-07-03
US08/731,605 1996-10-16
US08/731,605 US5958378A (en) 1996-07-03 1996-10-16 High dose liposomal aerosol formulations containing cyclosporin A or budesonide

Publications (2)

Publication Number Publication Date
CN1224347A CN1224347A (zh) 1999-07-28
CN1094345C true CN1094345C (zh) 2002-11-20

Family

ID=27101390

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97196141A Expired - Fee Related CN1094345C (zh) 1996-07-03 1997-07-02 高剂量脂质体气溶胶制剂

Country Status (10)

Country Link
EP (1) EP0959874B1 (enExample)
JP (1) JP2001524930A (enExample)
CN (1) CN1094345C (enExample)
AT (2) ATE268163T1 (enExample)
AU (1) AU732124B2 (enExample)
CA (1) CA2259185C (enExample)
DE (2) DE69736083T2 (enExample)
NZ (1) NZ333497A (enExample)
TW (1) TW497974B (enExample)
WO (1) WO1998000111A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417172B1 (en) * 1995-06-05 2002-07-09 Eisai Co., Ltd. Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
US5863910A (en) * 1996-01-12 1999-01-26 Bolonick; Joel Treatment of chronic inflammatory disorders of the gastrointestinal tract
US7348025B2 (en) 1997-09-23 2008-03-25 Research Development Foundation Small particle liposome aerosols for delivery of anticancer drugs
US6090407A (en) * 1997-09-23 2000-07-18 Research Development Foundation Small particle liposome aerosols for delivery of anti-cancer drugs
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US20020006901A1 (en) 1999-02-05 2002-01-17 Aldo T. Iacono Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
NZ515644A (en) * 1999-06-04 2004-12-24 Skyepharma Inc Oil-core compositions for the sustained release of hydrophobic drugs
IL150027A0 (en) * 1999-12-04 2002-12-01 Res Dev Foundation Carbon dioxide enhancement of inhalation therapy
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
AU6124601A (en) 2000-05-10 2001-11-20 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
EP1506032A1 (en) * 2002-05-20 2005-02-16 Research Development Foundation Aerosol drug inhibition of lung metastases
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
RU2468797C2 (ru) 2005-06-09 2012-12-10 Биолипокс Аб Способ и композиция для лечения воспалительных нарушений
DE102006051512A1 (de) * 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin
CN101502484B (zh) * 2006-12-26 2011-04-20 济南康泉医药科技有限公司 同载糖皮质激素和化疗药物的抗癌缓释剂
WO2009062193A2 (en) * 2007-11-09 2009-05-14 Map Pharmaceuticals, Inc. Methods for administering corticosteroid formulations
CA3022054A1 (en) 2010-03-12 2011-09-15 Berg Llc Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
US20130209550A1 (en) 2010-07-28 2013-08-15 Life Technologies Corporation Anti-Viral Azide Containing Compounds
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
KR20130109106A (ko) * 2010-08-05 2013-10-07 피라말 엔터프라이지즈 리미티드 감염성 질환 치료용 항감염 분자의 폐로의 약물 운반을 위한 미세입자 제형
CN102008713B (zh) * 2010-12-02 2012-10-24 深圳海王药业有限公司 环孢素a前体脂质体、药物组合物及其制备方法
CN103732214B (zh) * 2011-06-17 2017-04-12 博格有限责任公司 可吸入药物组合物
GB201114332D0 (en) 2011-08-19 2011-10-05 Nufarm Uk Ltd Novel inhibitor compositions and methods of use
CN108977412A (zh) 2012-01-26 2018-12-11 生命科技公司 用于提高病毒感染性的方法
CA3104443A1 (en) * 2018-06-27 2020-01-02 Breath Therapeutics Gmbh Inhalable compositions comprising macrocyclic immunosuppressants
JP7401471B2 (ja) 2018-06-27 2023-12-19 ブレス テラポイティクス ゲーエムベーハー 凍結乾燥形態の医薬組成物
EA202092892A1 (ru) 2018-12-04 2021-05-27 Брес Терапьютикс Гмбх Ингаляционные композиции, содержащие макроциклические иммуносупрессанты

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
IE63869B1 (en) * 1986-11-06 1995-06-14 Res Dev Foundation Aerosols containing liposomes and method for their preparation
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
MX9201782A (es) * 1991-04-19 1992-10-01 Sandoz Ag Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
DE4203306A1 (de) * 1992-02-06 1993-08-12 Ig Spruehtechnik Gmbh Asthma oder pulmonal-aerosolzubereitungen mit lecithin
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA119:256383 1993.1.1 WALDREP.CYCLOSPORIN A LIPOSOME AEROSOL:PARTICLE SIZE AND CALCULATED RESPIRATORY DEPOSITION *

Also Published As

Publication number Publication date
AU732124B2 (en) 2001-04-12
EP0959874A1 (en) 1999-12-01
DE69729391D1 (de) 2004-07-08
NZ333497A (en) 2000-06-23
DE69729391T2 (de) 2005-06-02
EP0959874B1 (en) 2004-06-02
ATE328583T1 (de) 2006-06-15
CN1224347A (zh) 1999-07-28
CA2259185C (en) 2009-12-15
TW497974B (en) 2002-08-11
ATE268163T1 (de) 2004-06-15
DE69736083T2 (de) 2006-12-28
WO1998000111A1 (en) 1998-01-08
JP2001524930A (ja) 2001-12-04
CA2259185A1 (en) 1998-01-08
EP0959874A4 (enExample) 1999-12-22
DE69736083D1 (de) 2006-07-20
AU3650897A (en) 1998-01-21

Similar Documents

Publication Publication Date Title
CN1094345C (zh) 高剂量脂质体气溶胶制剂
US5958378A (en) High dose liposomal aerosol formulations containing cyclosporin A or budesonide
US5049389A (en) Novel liposome composition for the treatment of interstitial lung diseases
US5192528A (en) Corticosteroid inhalation treatment method
US5043165A (en) Novel liposome composition for sustained release of steroidal drugs
US20070065369A1 (en) Novel methods and composition for delivering macromolecules to or via the respiratory tract
CN100513417C (zh) 用于雾化的环索奈德水悬液
TW200916126A (en) Organic compounds
CN108348459A (zh) 靶向递送喷雾干燥制剂到肺
US20240226116A1 (en) Glucocorticoid Particles and Their Use
CN1681520A (zh) 脱氢表雄酮的喷雾剂和采用其组合物治疗哮喘或慢性阻塞性肺部疾病的方法
WO1990006775A1 (en) A novel nonphospholipid liposome composition for sustained release of drugs
CN115768404B (zh) 含乌美溴铵和三苯乙酸维兰特罗的药物制剂
US20020076383A1 (en) Composition and method for treatment of otitis external
EP2983646A1 (en) A pharmaceutical composition containing budesonide and formoterol.
US6645467B2 (en) Composition and method for decreasing upper respiratory airway resistance
RU2174390C2 (ru) Высокодозированные липосомные аэрозольные фармацевтические композиции
DK2704724T3 (en) Improved suspension formulation of beclomethasone dipropionate for administration by inhalation
US7141236B2 (en) Methods and compositions for delivering macromolecules to or via the respiratory tract
EP1390012A1 (en) Novel methods and compositions for delivering macromolecules to or via the respiratory tract
KR100497564B1 (ko) 고용량의리포좀에어로졸제제
WO2015009776A1 (en) Low dose corticosteroid microemulsion compositions and methods of treatments thereof
Khale et al. Liposomal Nebulising Solutions of Salbutamol Sulphate-A Characterisation Study
CN115835885A (zh) 包含奥达特罗和布地奈德的药物组合物的制备

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20021120

Termination date: 20120702